Omada empowers people across the chronic disease spectrum to set and reach their health goals.
Our digital behavior change program is personalized to support people at risk for, or living with, chronic conditions—as their needs evolve.
“The employee feedback is just overwhelmingly positive. It’s been the fastest program we’ve ever had at Lowe’s to go viral.”
We surround participants with the tools and support they
need to build long-term healthy habits.
Omada’s highly trained coaches are empowered with data to deliver guidance in moments that matter.
We send participants a wireless scale to keep and offer smart device integration for seamless tracking.
Participants are matched with a small group of peers for motivation, encouragement, and empathy.
From meditation to medication, our tailored content is designed to have an immediate—and lasting—impact.
Each day, we empower participants to reach their unique goals through a customized to-do list.
As the largest CDC-recognized digital Diabetes Prevention Program, we’ve inspired nearly 200,000 participants to take their health into their own hands.
Testimonials are based on the participants’ real experiences using the Omada Program and are not necessarily representative of all persons who will use our program. They are based on individual results, and results may vary based on age, gender and other individual and demographic factors. We do not claim that they are typical results that participants will generally achieve.
1. Centers for Disease Control and Prevention. Prediabetes. http://www.cdc.gov/diabetes/basics/prediabetes.html. Accessed August 30, 2018; last reviewed July 21, 2018.
2. Centers for Disease Control and Prevention. Diabetes Prevention. https://www.cdc.gov/diabetes/diabetesatwork/diabetes-basics/prevention.html#searchTarge. Accessed September 4, 2018; last reviewed December 29, 2016.
3. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: US Department of Health and Human Services; 2017.
4. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016 Jul 22;10:1299-307. doi: 10.2147/PPA.S106821. eCollection 2016.
5. Data reflects both type 1 and type 2 diabetes. American Diabetes Association. http://www.diabetes.org/diabetes-basics/statistics/. March 22, 2018.
6. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269-1324, pg138. doi: 10.1161/HYP.0000000000000066.
7. Merai R, Siegel C, Rakotz M, Basch P, Wright J, Wong B; DHSc., Thorpe P. CDC Grand Rounds: A Public Health Approach to Detect and Control Hypertension. MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1261-1264
8. Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627-2646. http://dx.doi.org/10.1001/jama.2016.16885.
9. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e271. Prevalence of conditions applies to adults age 20+ in the US.
10. Centers for Disease Control and Prevention. https://www.cdc.gov/cholesterol/facts.htm. Published October 31, 2017.
